CRDF Stock-Based Compensation
Cardiff Oncology Inc · Stock-Based Compensation
CRDF Stock-Based Compensation
Latest reported$5.23Mperiod ending
CRDF Stock-Based Comp ($0.00 → $5.23M)
Annual stock-based compensation
High-resolution chart · PNG
CRDF stock-based compensation history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 5,693,000 | |
| 4,760,000 | |
| 4,509,000 | |
| 4,256,000 | |
| 3,234,000 | |
| 1,765,000 | |
| 885,000 | |
| 2,175,000 | |
| 4,013,000 | |
| 7,504,000 | |
| 3,946,027 | |
| 2,070,194 | |
| 1,979,364 | |
| 532,140 | |
| 250,978 | |
| 325,930 | |
| 0 | |
| 0 |